Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Mitozolomide
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.079.921 |
Chemical and physical data | |
Formula | C7H7ClN6O2 |
Molar mass | 242.62 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Mitozolomide (INN) is an antineoplastic. It is an imidazotetrazine derivative.
Development of mitozolomide was discontinued during Phase II clinical trials after it was found to cause severe and unpredictable bone marrow suppression.Temozolomide, which has been in clinical use since 1999, is a less toxic analogue of mitozolomide.